Page last updated: 2024-11-03

ag 1879 and Acute Lymphoid Leukemia

ag 1879 has been researched along with Acute Lymphoid Leukemia in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Research Excerpts

ExcerptRelevanceReference
"MLL-rearranged acute lymphoblastic leukemia (ALL) in infants is characterized by a poor clinical outcome and resistance to glucocorticoids (for example, prednisone and dexamethasone)."1.38Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. ( de Boer, J; Hulleman, E; Pieters, R; Schneider, P; Spijkers-Hagelstein, JA; Stam, RW; Williams, O, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spijkers-Hagelstein, JA1
Schneider, P1
Hulleman, E1
de Boer, J1
Williams, O1
Pieters, R1
Stam, RW1

Other Studies

1 other study available for ag 1879 and Acute Lymphoid Leukemia

ArticleYear
Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
    Leukemia, 2012, Volume: 26, Issue:6

    Topics: Apoptosis; Blotting, Western; Calgranulin A; Calgranulin B; Drug Resistance, Neoplasm; Flow Cytometr

2012